We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Recombinant Data Named Finalist in "Most Promising Company" Competition

News   Feb 09, 2012

 
Recombinant Data Named Finalist in "Most Promising Company" Competition
 
 
Advertisement
 

RELATED ARTICLES

Nanoneedles Make for More Robust Digital Memories

News

Researchers have developed a new technique to locally modify the properties of a metamagnetic material, which could increase the capacity and robustness of digital memories.

READ MORE

App Calculates Risk of Postponing Cancer Care During COVID-19 Pandemic

News

A team from The University of Michigan has created the "OncCOVID app". This new app draws on global cancer and coronavirus data to create an individualized mortality risk assessment for receiving immediate versus delayed cancer treatment.

READ MORE

Olaparib Approved as Gene-targeted Medicine for Prostate Cancer

News

Olaparib is a precision medicine that works by selectively targeting and killing cancer cells with faulty DNA repair machinery. On May 19, 2020, the Food and Drug Administration (FDA) approved olaparib for adult patients with a specific type of prostate cancer .

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE